Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 10, 2026

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

4.1K

Surgical Challenges After Neoadjuvant Therapy.

Olga Ostrovetsky1, Neel P Chudgar1

  • 1Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

Thoracic Surgery Clinics
|November 19, 2025
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Who Gets Left Out of Precision Oncology? Real-World Driver Mutation Expression Patterns and Therapeutic Eligibility in a Diverse Single-Center Early-Stage Lung Adenocarcinoma Cohort.

Journal of racial and ethnic health disparities·2026
Same author

A contemporary nationwide analysis of neoadjuvant regimens for esophageal adenocarcinoma.

JTCVS open·2026
Same author

Patients with high distressed communities index score are at risk for "no-show" to lung cancer screening appointments.

JTCVS open·2026
Same author

Advancing the early detection of lung cancer: Outcomes of a surgeon-led lung nodule clinic in a distressed patient population.

JTCVS open·2026
Same author

Does Robotic Surgery Offer Advantages Over Thoracoscopic Surgery for Patients Undergoing Wedge Resection for Non-Small Cell Lung Cancer?

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

The Society of Thoracic Surgeons (2025) Expert Consensus Document on Interventions for Screen-Detected Lung Nodules.

The Annals of thoracic surgery·2026
Same journal

Pleuropulmonary Infectious Diseases: Impact of the Diseases and the Scarce Literature.

Thoracic surgery clinics·2026
Same journal

TB or Not TB-Septic or Resect? That Is the Question.

Thoracic surgery clinics·2026
Same journal

Surgery for Pulmonary Aspergillosis.

Thoracic surgery clinics·2026
Same journal

Current Treatment for Mediastinitis.

Thoracic surgery clinics·2026
Same journal

Surgical Management of Pulmonary Mucormycosis.

Thoracic surgery clinics·2026
Same journal

Surgical Management of Pulmonary Hydatid Disease.

Thoracic surgery clinics·2026
See all related articles

Neoadjuvant chemoimmunotherapy and EGFR-TKI treatments improve outcomes for early-stage non-small cell lung cancer. Surgeons must understand therapy-induced tissue changes for optimal surgical management in this evolving treatment landscape.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Research

Background:

  • Neoadjuvant chemoimmunotherapy and epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) show promise for early-stage, resectable non-small cell lung cancer.
  • These therapies are associated with improved pathologic response rates, indicating significant tumor reduction.

Purpose of the Study:

  • To highlight the implications of neoadjuvant therapies on surgical management for non-small cell lung cancer.
  • To prepare surgeons for potential challenges arising from therapy-induced tissue alterations in the real-world setting.

Main Methods:

  • Review of current clinical trial data and therapeutic strategies.
  • Analysis of the impact of neoadjuvant chemoimmunotherapy and EGFR-TKIs on lung tissue.
Keywords:
ChemoimmunotherapyLung cancerNeoadjuvant therapySurgical complexityTyrosine kinase inhibitor

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K
A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

30.4K

Related Experiment Videos

Last Updated: Jan 10, 2026

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

4.1K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K
A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

30.4K

Main Results:

  • Neoadjuvant chemoimmunotherapy and EGFR-TKIs lead to enhanced pathologic response rates in early-stage NSCLC.
  • Therapeutic interventions cause significant tissue changes that can affect surgical approaches.

Conclusions:

  • The increasing use of these neoadjuvant treatments necessitates a surgeon's awareness of potential intraoperative challenges.
  • Bridging clinical trial findings with practical surgical considerations is crucial for effective patient care in non-small cell lung cancer.